Investigating how inflammatory signals affect nerve cell survival in neurodegenerative diseases

Anti-inflammatory signals and neurodegeneration

NIH-funded research San Diego Biomedical Research Institute · NIH-10928425

This study is looking at how certain signals in the brain might affect the survival of nerve cells in people with Parkinson's disease, with the hope of finding new ways to protect these important cells and slow down the disease.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionSan Diego Biomedical Research Institute NIH-funded
Lab location1 site (San Diego, United States)
Project IDNIH-10928425 on NIH RePORTER

What this research studies

This research focuses on understanding the role of specific inflammatory signals in the survival of nerve cells, particularly in the context of neurodegenerative diseases like Parkinson's disease. The study examines how the activation of certain receptors in the brain can lead to the death of dopamine-producing neurons, which are crucial for movement and coordination. By using a mouse model, the researchers aim to explore the mechanisms behind this cell death and how it relates to inflammation and oxidative stress. The ultimate goal is to identify potential therapeutic targets that could help slow down neurodegeneration in affected individuals.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Parkinson's disease or those at risk of developing neurodegenerative conditions.

Not a fit: Patients with neurodegenerative diseases not related to inflammation or those without a diagnosis of Parkinson's disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that slow the progression of neurodegenerative diseases like Parkinson's.

How similar studies have performed: Previous research has shown promising results in targeting inflammatory pathways to protect nerve cells, suggesting that this approach could be effective.

Where this research is happening

San Diego, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's Disease
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.